Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Jazz Pharmaceuticals plcJAZZ · Entity 818 | Director | August 31, 2026 | September 02, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Jazz Pharmaceuticals plc
Report date August 31, 2026 · Filed September 02, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 18,199 |
Ending reported balance
After 2026-08-31 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-08-31 · Tax withholding · Disposed 15 · Balance 20,039 F1: Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. Row 2 · 2026-08-31 · Tax withholding · Disposed 1,840 · Balance 18,199 F1: Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 31, 2026 Filed Sep 2, 2026 21:13 UTC | Jazz Pharmaceuticals plc JAZZ · Entity 818 | Tax withholdingOrdinary Shares | 1,840 | $241.39 | $444,157.60 |
DisclosureSEC source: 0001576068-26-000009 · edgardoc.xml · nonDerivative · entry 2 McSharry Heather Ann · CIK 0001576068 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,199 F1 · kind: Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. Read SEC document |
| August 31, 2026 Filed Sep 2, 2026 21:13 UTC | Jazz Pharmaceuticals plc JAZZ · Entity 818 | Tax withholdingOrdinary Shares | 15 | $244.64 | $3,669.67 |
DisclosureSEC source: 0001576068-26-000009 · edgardoc.xml · nonDerivative · entry 1 McSharry Heather Ann · CIK 0001576068 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,039 F1 · kind: Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. Read SEC document |
| August 05, 2026 Filed Aug 7, 2026 21:39 UTC | Jazz Pharmaceuticals plc JAZZ · Entity 818 | GrantOrdinary Shares | 1,605 | $0.00 | $0.00 |
DisclosureSEC source: 0001576068-26-000004 · edgardoc.xml · nonDerivative · entry 1 McSharry Heather Ann · CIK 0001576068 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,054 F1 · kind: These restricted stock units are granted pursuant to the Issuer's 2007 Amended and Restated Non-Employee Directors Stock Award Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. Subject to the Reporting Person's continuous service and certain additional conditions, these units will vest in full on July 23, 2027. Read SEC document |
| May 22, 2026 Filed May 27, 2026 22:07 UTC | Jazz Pharmaceuticals plc JAZZ · Entity 818 | SaleOrdinary Shares | 2,000 | $241.00 | $482,000.00 |
DisclosureSEC source: 0001576068-26-000002 · edgardoc.xml · nonDerivative · entry 1 McSharry Heather Ann · CIK 0001576068 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,449 Read SEC document |
| November 20, 2025 Filed Nov 24, 2025 22:47 UTC | Jazz Pharmaceuticals plc JAZZ · Entity 818 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 3,415 | $0.00 Strike: $138.08 | $0.00 |
DisclosureSEC source: 0001576068-25-000005 · edgardoc.xml · derivative · entry 3 McSharry Heather Ann · CIK 0001576068 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 3,415 shares Expires 2026-08-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: This non-qualified stock option was granted on August 11, 2016 and vested over a period of one year from September 1, 2016. The options were fully vested as of August 1, 2017. Read SEC document |
| November 20, 2025 Filed Nov 24, 2025 22:47 UTC | Jazz Pharmaceuticals plc JAZZ · Entity 818 | SaleOrdinary Shares | 3,415 | $177.78 | $607,126.55 |
DisclosureSEC source: 0001576068-25-000005 · edgardoc.xml · nonDerivative · entry 2 McSharry Heather Ann · CIK 0001576068 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,449 Read SEC document |
| November 20, 2025 Filed Nov 24, 2025 22:47 UTC | Jazz Pharmaceuticals plc JAZZ · Entity 818 | Exercise / conversionOrdinary Shares | 3,415 | $138.08 | $471,543.20 |
DisclosureSEC source: 0001576068-25-000005 · edgardoc.xml · nonDerivative · entry 1 McSharry Heather Ann · CIK 0001576068 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,864 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 08, 2025 Filed Aug 11, 2025 21:40 UTC | Jazz Pharmaceuticals plc JAZZ · Entity 818 | Tax withholdingOrdinary Shares | 1,959 | $111.25 | $217,938.16 |
DisclosureSEC source: 0001765581-25-000086 · edgardoc.xml · nonDerivative · entry 2 McSharry Heather Ann · CIK 0001576068 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,449 F2 · kind: Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. Read SEC document |
| August 07, 2025 Filed Aug 11, 2025 21:40 UTC | Jazz Pharmaceuticals plc JAZZ · Entity 818 | GrantOrdinary Shares | 3,507 | $0.00 | $0.00 |
DisclosureSEC source: 0001765581-25-000086 · edgardoc.xml · nonDerivative · entry 1 McSharry Heather Ann · CIK 0001576068 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,408 F1 · kind: These restricted stock units are granted pursuant to the Issuer's 2007 Amended and Restated Non-Employee Directors Stock Award Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. Subject to the Reporting Person's continuous service and certain additional conditions, these units will vest in full on July 24, 2026. Read SEC document |
| August 06, 2024 Filed Aug 6, 2024 22:39 UTC | Jazz Pharmaceuticals plc JAZZ · Entity 818 | Tax withholdingOrdinary Shares | 1,608 | $111.35 | $179,050.80 |
DisclosureSEC source: 0001765581-24-000074 · edgardoc.xml · nonDerivative · entry 2 McSharry Heather Ann · CIK 0001576068 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,901 F2 · kind: Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. Read SEC document |
| August 02, 2024 Filed Aug 6, 2024 22:39 UTC | Jazz Pharmaceuticals plc JAZZ · Entity 818 | GrantOrdinary Shares | 3,731 | $0.00 | $0.00 |
DisclosureSEC source: 0001765581-24-000074 · edgardoc.xml · nonDerivative · entry 1 McSharry Heather Ann · CIK 0001576068 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,509 F1 · kind: These restricted stock units are granted pursuant to the Issuer's 2007 Amended and Restated Non-Employee Directors Stock Award Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. Subject to the Reporting Person's continuous service and certain additional conditions, these units will vest in full on July 25, 2025. Read SEC document |
| August 14, 2023 Filed Aug 15, 2023 21:52 UTC | Jazz Pharmaceuticals plc JAZZ · Entity 818 | SaleOrdinary Shares | 1,344 | $138.16 | $185,685.16 |
DisclosureSEC source: 0001765581-23-000084 · edgardoc.xml · nonDerivative · entry 2 McSharry Heather Ann · CIK 0001576068 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,778 F2 · kind: Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. F3 · price: Reflects the sale of ordinary shares executed in multiple transactions at prices ranging from $137.78 to $138.16. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. Read SEC document |
| August 11, 2023 Filed Aug 15, 2023 21:52 UTC | Jazz Pharmaceuticals plc JAZZ · Entity 818 | GrantOrdinary Shares | 3,075 | $0.00 | $0.00 |
DisclosureSEC source: 0001765581-23-000084 · edgardoc.xml · nonDerivative · entry 1 McSharry Heather Ann · CIK 0001576068 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,122 F1 · kind: Directors Stock Award Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. Subject to the Reporting Person's continuous service and certain additional conditions, these units will vest in full on August 3, 2024. Read SEC document |
| August 08, 2022 Filed Aug 9, 2022 22:24 UTC | Jazz Pharmaceuticals plc JAZZ · Entity 818 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 8,000 | $0.00 Strike: $55.28 | $0.00 |
DisclosureSEC source: 0001765581-22-000088 · edgardoc.xml · derivative · entry 5 McSharry Heather Ann · CIK 0001576068 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 8,000 shares Expires 2023-05-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option was granted pursuant to the Issuer's 2007 Non-Employee Directors Stock Option Plan. Subject to the Reporting Person's continuous service and certain additional conditions, this option vested over three years from the Vesting Commencement Date, with 1/3 that vested on the first anniversary of the Vesting Commencement Date and the remainder vested in 24 equal monthly installments thereafter. Read SEC document |
| August 08, 2022 Filed Aug 9, 2022 22:24 UTC | Jazz Pharmaceuticals plc JAZZ · Entity 818 | SaleOrdinary Shares | 5,500 | $154.59 | $850,268.10 |
DisclosureSEC source: 0001765581-22-000088 · edgardoc.xml · nonDerivative · entry 4 McSharry Heather Ann · CIK 0001576068 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,047 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $154.48 to $154.80, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| August 08, 2022 Filed Aug 9, 2022 22:24 UTC | Jazz Pharmaceuticals plc JAZZ · Entity 818 | Exercise / conversionOrdinary Shares | 8,000 | $55.28 | $442,240.00 |
DisclosureSEC source: 0001765581-22-000088 · edgardoc.xml · nonDerivative · entry 3 McSharry Heather Ann · CIK 0001576068 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,547 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 08, 2022 Filed Aug 9, 2022 22:24 UTC | Jazz Pharmaceuticals plc JAZZ · Entity 818 | SaleOrdinary Shares | 1,179 | $152.32 | $179,589.64 |
DisclosureSEC source: 0001765581-22-000088 · edgardoc.xml · nonDerivative · entry 2 McSharry Heather Ann · CIK 0001576068 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,547 F2 · kind: Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. Read SEC document |
| August 05, 2022 Filed Aug 9, 2022 22:24 UTC | Jazz Pharmaceuticals plc JAZZ · Entity 818 | GrantOrdinary Shares | 2,561 | $0.00 | $0.00 |
DisclosureSEC source: 0001765581-22-000088 · edgardoc.xml · nonDerivative · entry 1 McSharry Heather Ann · CIK 0001576068 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,726 F1 · kind: These restricted stock units are granted pursuant to the Issuer's 2007 Amended and Restated Non-Employee Directors Stock Award Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. Subject to the Reporting Person's continuous service and certain additional conditions, these units will vest in full on July 28, 2023. Read SEC document |
| August 06, 2021 Filed Aug 10, 2021 21:35 UTC | Jazz Pharmaceuticals plc JAZZ · Entity 818 | SaleOrdinary Shares | 1,414 | $147.96 | $209,215.44 |
DisclosureSEC source: 0001765581-21-000104 · edgardoc.xml · nonDerivative · entry 1 McSharry Heather Ann · CIK 0001576068 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,165 F1 · kind: Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. Read SEC document |
| July 29, 2021 Filed Aug 2, 2021 22:16 UTC | Jazz Pharmaceuticals plc JAZZ · Entity 818 | GrantOrdinary Shares | 2,246 | $0.00 | $0.00 |
DisclosureSEC source: 0001765581-21-000073 · edgardoc.xml · nonDerivative · entry 1 McSharry Heather Ann · CIK 0001576068 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,579 F1 · kind: These restricted stock units are granted pursuant to the Issuer's 2007 Amended and Restated Non-Employee Directors Stock Award Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. Subject to the Reporting Person's continuous service and certain additional conditions, these units will vest in full on July 29, 2022. Read SEC document |
| August 07, 2020 Filed Aug 10, 2020 20:45 UTC | Jazz Pharmaceuticals plc JAZZ · Entity 818 | SaleOrdinary Shares | 1,009 | $125.87 | $127,003.44 |
DisclosureSEC source: 0001765581-20-000073 · edgardoc.xml · nonDerivative · entry 2 McSharry Heather Ann · CIK 0001576068 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,333 F2 · kind: Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. Read SEC document |
| August 06, 2020 Filed Aug 10, 2020 20:45 UTC | Jazz Pharmaceuticals plc JAZZ · Entity 818 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 6,765 | $0.00 Strike: $127.07 | $0.00 |
DisclosureSEC source: 0001765581-20-000073 · edgardoc.xml · derivative · entry 3 McSharry Heather Ann · CIK 0001576068 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,765 Underlying: Ordinary Shares · 6,765 shares Expires 2030-08-05 F3 · derivative.exercise_date: These options are granted pursuant to the Issuer's 2007 Amended and Restated Non-Employee Directors Stock Award Plan. Subject to the Reporting Person's continuous service and certain additional conditions, these options will vest in full on July 30, 2021. Read SEC document |
| August 06, 2020 Filed Aug 10, 2020 20:45 UTC | Jazz Pharmaceuticals plc JAZZ · Entity 818 | GrantOrdinary Shares | 2,705 | $0.00 | $0.00 |
DisclosureSEC source: 0001765581-20-000073 · edgardoc.xml · nonDerivative · entry 1 McSharry Heather Ann · CIK 0001576068 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,342 F1 · kind: These restricted stock units are granted pursuant to the Issuer's 2007 Amended and Restated Non-Employee Directors Stock Award Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. Subject to the Reporting Person's continuous service and certain additional conditions, these units will vest in full on July 30, 2021. Read SEC document |
| August 09, 2019 Filed Aug 12, 2019 21:26 UTC | Jazz Pharmaceuticals plc JAZZ · Entity 818 | SaleOrdinary Shares | 787 | $135.65 | $106,755.61 |
DisclosureSEC source: 0001765581-19-000066 · edgardoc.xml · nonDerivative · entry 2 McSharry Heather Ann · CIK 0001576068 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,637 F2 · kind: Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. F3 · price: Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $135.4549 to $135.65. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. Read SEC document |
| August 08, 2019 Filed Aug 12, 2019 21:26 UTC | Jazz Pharmaceuticals plc JAZZ · Entity 818 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 4,805 | $0.00 Strike: $137.12 | $0.00 |
DisclosureSEC source: 0001765581-19-000066 · edgardoc.xml · derivative · entry 3 McSharry Heather Ann · CIK 0001576068 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,805 Underlying: Ordinary Shares · 4,805 shares Expires 2029-08-07 F4 · kind: These options are granted pursuant to the Issuer's 2007 Non-Employee Directors Stock Award Plan. Subject to the Reporting Person's continuous service and certain additional conditions, these options will vest in 12 equal monthly installments beginning on September 1, 2019. F4 · derivative.exercise_date: These options are granted pursuant to the Issuer's 2007 Non-Employee Directors Stock Award Plan. Subject to the Reporting Person's continuous service and certain additional conditions, these options will vest in 12 equal monthly installments beginning on September 1, 2019. Read SEC document |
| August 08, 2019 Filed Aug 12, 2019 21:26 UTC | Jazz Pharmaceuticals plc JAZZ · Entity 818 | GrantOrdinary Shares | 1,920 | $0.00 | $0.00 |
DisclosureSEC source: 0001765581-19-000066 · edgardoc.xml · nonDerivative · entry 1 McSharry Heather Ann · CIK 0001576068 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,424 F1 · kind: These restricted stock units are granted pursuant to the Issuer's 2007 Non-Employee Directors Stock Award Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. Subject to the Reporting Person's continuous service and certain additional conditions, these units will vest in full on August 1, 2020. Read SEC document |
| August 10, 2018 Filed Aug 13, 2018 22:38 UTC | Jazz Pharmaceuticals plc JAZZ · Entity 818 | SaleOrdinary Shares | 715 | $176.61 | $126,276.44 |
DisclosureSEC source: 0001232524-18-000146 · edgardoc.xml · nonDerivative · entry 2 McSharry Heather Ann · CIK 0001576068 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,504 F2 · kind: Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. F3 · price: Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $176.61 to $176.9217. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. Read SEC document |
| August 09, 2018 Filed Aug 13, 2018 22:38 UTC | Jazz Pharmaceuticals plc JAZZ · Entity 818 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 3,735 | $0.00 Strike: $177.73 | $0.00 |
DisclosureSEC source: 0001232524-18-000146 · edgardoc.xml · derivative · entry 3 McSharry Heather Ann · CIK 0001576068 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,735 Underlying: Ordinary Shares · 3,735 shares Expires 2028-08-08 F4 · kind: These options are granted pursuant to the Issuer's 2007 Non-Employee Directors Stock Award Plan. Subject to the Reporting Person's continuous service and certain additional conditions, these options will vest in 12 equal monthly installments beginning on September 1, 2018. F4 · derivative.exercise_date: These options are granted pursuant to the Issuer's 2007 Non-Employee Directors Stock Award Plan. Subject to the Reporting Person's continuous service and certain additional conditions, these options will vest in 12 equal monthly installments beginning on September 1, 2018. Read SEC document |
| August 09, 2018 Filed Aug 13, 2018 22:38 UTC | Jazz Pharmaceuticals plc JAZZ · Entity 818 | GrantOrdinary Shares | 1,495 | $0.00 | $0.00 |
DisclosureSEC source: 0001232524-18-000146 · edgardoc.xml · nonDerivative · entry 1 McSharry Heather Ann · CIK 0001576068 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,219 F1 · kind: These restricted stock units are granted pursuant to the Issuer's 2007 Non-Employee Directors Stock Award Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. Subject to the Reporting Person's continuous service and certain additional conditions, these units will vest in full on August 2, 2019. Read SEC document |
| August 11, 2017 Filed Aug 14, 2017 21:21 UTC | Jazz Pharmaceuticals plc JAZZ · Entity 818 | SaleOrdinary Shares | 3 | $144.13 | $432.38 |
DisclosureSEC source: 0001232524-17-000142 · edgardoc.xml · nonDerivative · entry 3 McSharry Heather Ann · CIK 0001576068 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,724 F2 · kind: Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. Read SEC document |
| August 11, 2017 Filed Aug 14, 2017 21:21 UTC | Jazz Pharmaceuticals plc JAZZ · Entity 818 | SaleOrdinary Shares | 714 | $142.36 | $101,645.04 |
DisclosureSEC source: 0001232524-17-000142 · edgardoc.xml · nonDerivative · entry 2 McSharry Heather Ann · CIK 0001576068 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,727 F2 · kind: Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. Read SEC document |
| August 10, 2017 Filed Aug 14, 2017 21:21 UTC | Jazz Pharmaceuticals plc JAZZ · Entity 818 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 3,415 | $0.00 Strike: $143.66 | $0.00 |
DisclosureSEC source: 0001232524-17-000142 · edgardoc.xml · derivative · entry 4 McSharry Heather Ann · CIK 0001576068 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,415 Underlying: Ordinary Shares · 3,415 shares Expires 2027-08-09 F3 · kind: These options are granted pursuant to the Issuer's 2007 Non-Employee Directors Stock Award Plan. Subject to the Reporting Person's continuous service and certain additional conditions, these options will vest in 12 equal monthly installments beginning on September 1, 2017. F3 · derivative.exercise_date: These options are granted pursuant to the Issuer's 2007 Non-Employee Directors Stock Award Plan. Subject to the Reporting Person's continuous service and certain additional conditions, these options will vest in 12 equal monthly installments beginning on September 1, 2017. Read SEC document |
| August 10, 2017 Filed Aug 14, 2017 21:21 UTC | Jazz Pharmaceuticals plc JAZZ · Entity 818 | GrantOrdinary Shares | 1,365 | $0.00 | $0.00 |
DisclosureSEC source: 0001232524-17-000142 · edgardoc.xml · nonDerivative · entry 1 McSharry Heather Ann · CIK 0001576068 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,441 F1 · kind: These restricted stock units are granted pursuant to the Issuer's 2007 Non-Employee Directors Stock Award Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. Subject to the Reporting Person's continuous service and certain additional conditions, these units will vest in full on August 3, 2018. F1 · shares: These restricted stock units are granted pursuant to the Issuer's 2007 Non-Employee Directors Stock Award Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. Subject to the Reporting Person's continuous service and certain additional conditions, these units will vest in full on August 3, 2018. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.